Skip to main content
. 2015 Feb 4;30(8):1081–1096. doi: 10.1007/s11606-015-3199-4

Table 4.

Adjusted Odds Ratios for Drug Overdose Associated with Significant Interactions of Opioid Analgesics and Selected Psychotherapeutic Drugs with Mental Health Conditions

Adjusted odds ratio (95 % CI)*
Opioid analgesic dose (average daily dose per 6-month interval) Depression=no Depression=yes
 0 mg 1 3.96 (3.00, 5.24)
 1–19 mg 0.80 (0.50, 1.27) 4.75 (3.24, 6.97)
 20–49 mg 1.54 (1.23, 1.94) 5.47 (4.23, 7.09)
 50–99 mg 2.08 (1.61, 2.69) 6.44 (4.85, 8.54)
 ≥100 mg 4.34 (3.37, 5.57) 7.06 (5.30, 9.42)
Antidepressant therapy (days per 6-month interval) Depression=no Depression=yes
 None 1 5.25 (4.25, 6.48)
 1–30 day 1.98 (1.48, 2.65) 5.51 (4.14, 7.34)
 31–90 day 1.59 (1.18, 2.15) 4.39 (3.39, 5.68)
 91–180 day 1.33 (1.05, 1.68) 4.15 (3.36, 5.12)
Benzodiazepine therapy (days per 6-month interval) Anxiety/PTSD=no Anxiety/PTSD=yes
 None 1 1.29 (0.99, 1.70)
 1–30 day 1.79 (1.41, 2.26) 2.20 (1.62, 3.00)
 31–90 day 2.62 (2.06, 3.34) 2.03 (1.49, 2.78)
 91–180 day 2.85 (2.34, 3.48) 2.56 (1.97, 3.32)
Zolpidem therapy (days per 6-month interval) Anxiety/PTSD=no Anxiety/PTSD=yes
 None 1 1.14 (0.97, 1.35)
 1–30 1.67 (1.21, 2.3) 1.14 (0.76, 1.72)
 31–90 1.06 (0.71, 1.57) 1.77 (1.25, 2.51)
 91–180 1.54 (1.2, 1.99) 1.30 (0.96, 1.77)

*Other variables in the model include: opioid daily MED category, time interval, age, gender, region, five chronic non-cancer pain conditions, anxiety/PTSD, depression, psychotic disorder, alcohol abuse, drug abuse, antidepressant therapy, benzodiazepine therapy and zolpidem per 6-month interval (four levels: none, 1–30 days, 31–90 days, 91–180 days)